The Swedish BioFINDER 2 Study

NARecruitingINTERVENTIONAL
Enrollment

1,505

Participants

Timeline

Start Date

May 15, 2017

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
DementiaAlzheimer DiseaseParkinson DiseaseLewy Body DiseaseParkinson-Dementia SyndromeFrontotemporal DegenerationSemantic DementiaProgressive Nonfluent AphasiaProgressive Supranuclear PalsyCorticobasal DegenerationMultiple System AtrophyMild Cognitive Impairment
Interventions
DIAGNOSTIC_TEST

Flutemetamol F18 Injection

PET imaging of Abeta amyloid

DIAGNOSTIC_TEST

[18F]-RO6958948

PET imaging of Tau aggregates

DIAGNOSTIC_TEST

Elecsys (Roche) Abeta42, Ttau and Ptau

Measurement of Abeta42, Ttau and Ptau in the cerebrospinal fluid

DIAGNOSTIC_TEST

Lumipulse (Fujirebio) Abeta42, Ttau and Ptau

Measurement of Abeta42, Ttau and Ptau in the cerebrospinal fluid

Trial Locations (2)

SE-262 81

RECRUITING

Memory Clinic, Hospital of Ängelholm, Ängelholm

SE-20502

RECRUITING

Memory Clinic, Skåne University Hospital, Malmo

All Listed Sponsors
collaborator

Lund University

OTHER

lead

Skane University Hospital

OTHER